Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Methimazole × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Cisplatin 899 Cyclophosphamide 848 Carboplatin 841 Radiotherapy 785 Bevacizumab 742 Gemcitabine 714 pembrolizumab 666 Docetaxel 657 Paclitaxel 649 Oxaliplatin 615 Capecitabine 574 Fluorouracil 513 Rituximab 501 Nivolumab 442 Dexamethasone 436 Etoposide 413 Doxorubicin 403 Irinotecan 395 Leucovorin 339 Drug Therapy 338 Cytarabine 302 Cetuximab 296 Lenalidomide 289 Trastuzumab 283 Pemetrexed 282 durvalumab 266 Filgrastim 252 Magnetic Resonance Spectroscopy 241 Prednisone 240 Temozolomide 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05607407 2026-03-04

Methimazole in Patients With Progressive Glioblastoma

Case Comprehensive Cancer Center

Phase 2 Recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡